Eva Feldman, MD, PhD, is a physician-scientist at the University of Michigan, Ann Arbor, US. She is Director of the University of Michigan ALS (Amyotrophic Lateral Sclerosis) Center of Excellence. She also runs her own laboratory, the NeuroNetwork for Emerging Therapies, where she has devoted her career to the study of neurological diseases, with an emphasis on ALS and neuropathies, including diabetic neuropathy.
In the podcast below, Dr. Feldman speaks with PRF Correspondent Sara Hakim, a PhD student at Harvard Medical School, Boston, US, to discuss the problem of diabetic neuropathy, its causes and treatment, and her lab studies of this condition.
